Clinical Trial Update: The EMPA-FIT Study [Phase 4]

View source ↗

Summary

This document reports an ongoing Phase 4 clinical trial named EMPA-FIT investigating empagliflozin in adults with Type 2 diabetes that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes, Diabetes Mellitus, Type II | Phase 4 | Status: RECRUITING